Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow ALGN
Align Technology, Inc. (ALGN) EBITDA
Align Technology, Inc.'s EBITDA for fiscal 2025 was $783.2M, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $802.0M. Over the past ten years it has ranged from $206.6M (fiscal 2015) to $1.1B (fiscal 2021); the current reading is higher than 82% of that period. Align Technology, Inc. ranks 10th of 50 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $783.2M | 4.06% |
| FY2024 | $752.7M | (4.21%) |
| FY2023 | $785.7M | 2.26% |
| FY2022 | $768.4M | (29.19%) |
| FY2021 | $1.1B | 125.74% |
| FY2020 | $480.7M | (22.65%) |
| FY2019 | $621.5M | 19.22% |
| FY2018 | $521.3M | 33.20% |
| FY2017 | $391.4M | 43.39% |
| FY2016 | $272.9M | 32.08% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $194.1M | (2.20%) |
| Mar 2026 | $198.5M | (22.86%) |
| Dec 2025 | $257.3M | 69.27% |
| Sep 2025 | $152.0M | (25.34%) |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| SOLV Solventum Corporation compare | $2.6B |
| BAX Baxter International Inc. compare | $1.5B |
| COO The Cooper Companies, Inc. compare | $928.2M |
| ALGN Align Technology, Inc. | $802.0M |
| ATR AptarGroup, Inc. compare | $784.6M |
| BLCO Bausch + Lomb Corporation compare | $749.0M |
| TFX Teleflex Incorporated compare | $256.2M |
| RGEN Repligen Corporation compare | $161.0M |
| AVTR Avantor, Inc. compare | $124.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement